Essa Pharma Inc (id:5569 EPIX)
1.61 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 9:17:47 AM)
Exchange closed, opens in 12 minutes
0.00 USD (0.00%)
-3.01 USD (-3.01%)
-6.40 USD (-6.40%)
-69.16 USD (-69.16%)
-74.84 USD (-74.84%)
-70.07 USD (-70.07%)
-98.11 USD (-98.11%)
About Essa Pharma Inc
Market Capitalization 71.02M
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
| Headquarters (address) |
999 West Broadway Vancouver V5Z 1K5 BC Canada |
| Phone | 778 331 0962 |
| Website | https://www.essapharma.com |
| Employees | 50 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | EPIX |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.40 - 11.67 |
| Market Capitalization | 71.02M |
| P/E trailing | -2.52 |
| P/E forward | -3.20 |
| Price/Book | 3.00 |
| Beta | 1.84 |
| EPS | 3.00 |
| EPS Canada (ID:82, base:720) | 2.18 |